The 72nd Annual Conference of the Israel Heart Society in association with the Israel Society of Cardiothoracic Surgery

Higher burden of cancer in patients with cardiovascular diseases

Tal Caller 1,2 Tal Hasin 3 Efrat Sharon 1,2 Ranel Loutati 2 Nili Naftali-Shani 1,2 Tomer Itkin 1,2 Jonathan Leor 1,2 Elad Maor 2,4
1Neufeld and Tamman Cardiovascular Research Institutes, School of Medicine, Tel Aviv University, Israel
2Lev Leviev Cardiovascular and Thoracic Center, Sheba Medical Center, Tel Hashomer, Israel
3Jesselson Integrated Heart Center, The Eisenberg R&D Authority, Shaare Zedek Medical Center, The Hebrew University, Jerusalem, Israel
4School of Medicine, Tel Aviv University, Israel

Introduction: Cardiovascular diseases (CVD) are associated with an increased risk of cancer. However, the association between CVD and second-primary cancer, cancer-related hospitalizations, or death wasn’t described.

Methods: We analyzed data from 109,204 adults, free of cancer at baseline, with valid echocardiography examination between 2000-2024. Cancer, CVD, hospitalization, and mortality data were obtained from Israel`s National Registries and institutional records. We used ICD9 codes to identify 2nd primary cancer. To avoid the detection of asymptomatic cancer, we implicated a 3-month blanking period at the start of the follow-up. Then, we used Cox regression and Poisson regression to assess the link between CVD and cancer incidence, hospitalizations, and death and to adjust for age, sex, BMI, smoking, and eGFR.

Results: During a median follow-up of 6.0 ± 4.4 years, there were 62,898 (58%) cases of CVD, and 4441 (4%) patients developed cancer; of them, 192 patients developed 2nd primary cancer. CVD was associated with an increased multivariable-adjusted risk of cancer (HR=1.53, 95%CI: 1.43-1.63, Figure 1A). CVD was also associated with a 13% higher incidence of second primary cancer (IRR=1.13, 95%CI: 1.04-1.15, Figure 1B), which is the development of another cancer type. Furthermore, CVD was also associated with a 2-fold increase in cancer-related hospitalizations in patients with cancer (1.64 vs 3.83 hospitalizations per year, IRR=2.05, 95%CI: 1.86-2.26, Figure 1C). Finally, we used interaction analysis to assess the link between CVD, cancer, and mortality. We found a significant interaction between CVD and cancer, indicating that the increased risk of death associated with cancer twice fold in patients with CVD (HR=2.05, 95%CI: 1.85-2.23, Figure 1D).

Conclusion: CVD, specifically atherosclerotic CVD and heart failure are associated with an increased risk of cancer and a higher cancer burden and mortality. Understanding this association could promote prevention, early diagnosis, and better treatment of cancer in patients with CVD.